这是一篇来自已证抗体库的有关
人类 Jak3的综述,是根据8篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Jak3 抗体。
Jak3 同义词: JAK-3; JAK3_HUMAN; JAKL; L-JAK; LJAK
圣克鲁斯生物技术
小鼠 单克隆(B-12) | | 圣克鲁斯生物技术 Jak3抗体(Santa Cruz, sc-6932)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 4). PLoS ONE (2016) ncbi |
赛信通(上海)生物试剂有限公司
domestic rabbit 多克隆 | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell Signaling Technology, 3775)被用于被用于免疫印迹在人类样本上 (图 s3b). Nat Cancer (2022) ncbi |
domestic rabbit 单克隆(D44E3) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell Signaling, 5031)被用于被用于免疫印迹在小鼠样本上 (图 1c). Cell Stem Cell (2019) ncbi |
domestic rabbit 单克隆(D1H3) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell signaling, 8827)被用于被用于免疫印迹在人类样本上 (图 3e). Nat Commun (2017) ncbi |
domestic rabbit 单克隆(D1H3) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell signaling, 8827)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 2b). Oncotarget (2017) ncbi |
小鼠 单克隆(5H2) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell Signaling, 5481)被用于被用于免疫印迹在人类样本上 (图 5d). Blood (2015) ncbi |
domestic rabbit 单克隆(D44E3) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell Signaling, 5031)被用于被用于免疫印迹在人类样本上. Proteomics (2015) ncbi |
domestic rabbit 单克隆(D44E3) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell Signaling Technology, 5031)被用于被用于免疫印迹在人类样本上. Cell Cycle (2014) ncbi |
domestic rabbit 单克隆(D1H3) | | 赛信通(上海)生物试剂有限公司 Jak3抗体(Cell Signaling Technology, 8827)被用于被用于免疫印迹在人类样本上. Cell Cycle (2014) ncbi |
Deng S, Wang C, Wang Y, Xu Y, Li X, Johnson N,
et al. Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nat Cancer. 2022;3:1071-1087
pubmed 出版商
Wang E, Dai Z, Ferrante A, Drake C, Christiano A. A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth. Cell Stem Cell. 2019;:
pubmed 出版商
Cayrol F, Praditsuktavorn P, Fernando T, Kwiatkowski N, Marullo R, Calvo Vidal M,
et al. THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors. Nat Commun. 2017;8:14290
pubmed 出版商
Cheng T, Zhai K, Chang Y, Yao G, He J, Wang F,
et al. CHIR99021 combined with retinoic acid promotes the differentiation of primordial germ cells from human embryonic stem cells. Oncotarget. 2017;8:7814-7826
pubmed 出版商
Zea A, Stewart T, Ascani J, Tate D, Finkel Jimenez B, Wilk A,
et al. Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?. PLoS ONE. 2016;11:e0157907
pubmed 出版商
McGirt L, Jia P, Baerenwald D, Duszynski R, Dahlman K, Zic J,
et al. Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood. 2015;126:508-19
pubmed 出版商
Osinalde N, Sánchez Quiles V, Akimov V, Guerra B, Blagoev B, Kratchmarova I. Simultaneous dissection and comparison of IL-2 and IL-15 signaling pathways by global quantitative phosphoproteomics. Proteomics. 2015;15:520-31
pubmed 出版商
Bao Y, Cao X, Luo D, Sun R, Peng L, Wang L,
et al. Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis. Cell Cycle. 2014;13:1958-69
pubmed 出版商